Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | CDC25A | P30304 | 1/20 | 0.40 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | BBOX1 | O75936 | 3/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | TERT | O14746 | 6/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.33 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.33 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.33 |
| ▸ | GMNN | O75496 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | HBB | P68871 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15819766 | 0.95 | HPGD (0.41) | HPGDALOX15CDC25ACTDSP1L3MBTL1 | |
| SCHEMBL1283707 | 0.83 | HPGD (0.42) | HPGDALOX15CDC25ACTDSP1L3MBTL1 | |
| SCHEMBL5009177 | 0.82 | BBOX1 (0.47) | HPGDALOX15CDC25ACTDSP1BBOX1 | |
| Sulfuric Acid SCHEMBL17102678 | 0.81 | CDC25A (0.50) | HPGDALOX15CDC25ACTDSP1L3MBTL1 | |
| SCHEMBL2396073 | 0.81 | BBOX1 (0.46) | HPGDCDC25ACTDSP1BBOX1TERT | |
| Sulfuric Acid SCHEMBL17102648 | 0.79 | CDC25A (0.48) | HPGDALOX15CDC25ACTDSP1L3MBTL1 | |
| SCHEMBL10256880 | 0.78 | HPGD (0.41) | HPGDALOX15CDC25ACTDSP1L3MBTL1 | |
| SCHEMBL9935685 | 0.77 | HPGD (0.58) | HPGDALOX15CDC25ACTDSP1L3MBTL1 | |
| SCHEMBL5011415 | 0.77 | BBOX1 (0.46) | HPGDCDC25ACTDSP1BBOX1SMN1; SMN2 | |
| SCHEMBL17102598 | 0.76 | CDC25A (0.49) | HPGDALOX15CDC25ACTDSP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230101362-A1 | RNA STABILIZATION | TEAM MEDICAL LLC | 2023-03-30 | — | — | US | claimed |
| EP-4361621-B1 | SAMPLE ANALYSIS METHOD, CAPILLARY ELECTROPHORESIS SOLUTION, AND SAMPLE ANALYSIS KIT | ARKRAY INC (JP) | 2026-04-08 | — | — | EP | disclosed |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | TEAM MEDICAL, LLC | 2025-09-18 | — | — | US | disclosed |
| US-20240159769-A1 | SAMPLE ANALYSIS METHOD, SAMPLE PRODUCTION METHOD, DILUENT FOR DILUTING ALBUMIN- AND y-GLOBULIN-CONTAINING SAMPLE, AND SAMPLE ANALYSIS KIT | ARKRAY, INC. (JP) | 2024-05-16 | — | — | US | disclosed |
| US-20240159705-A1 | SAMPLE ANALYSIS METHOD, CAPILLARY ELECTROPHORESIS SOLUTION, AND SAMPLE ANALYSIS KIT | ARKRAY, INC. (JP) | 2024-05-16 | — | — | US | disclosed |
| EP-4361622-A1 | SAMPLE ANALYSIS METHOD, SAMPLE PRODUCTION METHOD, DILUENT FOR DILUTING ALBUMIN- AND GAMMA-GLOBULIN-CONTAINING SAMPLE, AND SAMPLE ANALYSIS KIT | ARKRAY, Inc. (JP) | 2024-05-01 | — | — | EP | disclosed |
| EP-4361621-A1 | SAMPLE ANALYSIS METHOD, CAPILLARY ELECTROPHORESIS SOLUTION, AND SAMPLE ANALYSIS KIT | ARKRAY, Inc. (JP) | 2024-05-01 | — | — | EP | disclosed |
| US-20240115595-A1 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | TEAM MEDICAL, LLC (US) | 2024-04-11 | — | — | US | disclosed |
| WO-2024055011-A1 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | TEAM MEDICAL, LLC (US) | 2024-03-14 | — | — | WO | disclosed |
| US-20230101362-A1 | RNA STABILIZATION | TEAM MEDICAL LLC | 2023-03-30 | — | — | US | disclosed |
| WO-2023044455-A2 | RNA STABILIZATION | TEAM MEDICAL LLC (US) | 2023-03-23 | — | — | WO | disclosed |
| EP-3249054-A1 | FORMULATIONS AND METHODS FOR STABILIZING PCR REAGENTS | Biomatrica, INC. (US) | 2017-11-29 | — | — | EP | disclosed |
| US-9725703-B2 | Formulations and methods for stabilizing PCR reagents | BIOMATRICA, INC. (US) | 2017-08-08 | — | — | US | disclosed |
| US-20150329849-A1 | FORMULATIONS AND METHODS FOR STABILIZING PCR REAGENTS | MXCGLOBAL INC. | 2015-11-19 | — | — | US | disclosed |
| EP-1048669-A1 | CARBAPENEM DERIVATIVES | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2000-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240115595-A1 | MATERIAL COMPOSITIONS AND METHODS OF USE IMPROVING RNA STABILITY | RBM22, HNRNPUL2, HNRNPUL1 | HPGD 4599/4885ALOX15 3609/4885CDC25A 3728/4885 |
| US-20250289840-A1 | RNA STABILIZING SUBSTANCES AND METHODS OF USE | SYNCRIP, SNRPA, RNASE1 | HPGD 4461/4885ALOX15 1547/4885CDC25A 4227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.